Our intradermal delivery platforms ensure effective administration of small and large molecules, including vaccines, peptides, proteins, and biologics. With fully integrated capabilities and unrivaled experience in injectable combination products, Kindeva delivers unmatched microneedle array patch (MAP) capabilities.
Download our information sheet to discover:
- The far-reaching potential benefits of microneedle array patch technology across clinical, environmental, and usability considerations
- Our revolutionary solid and liquid delivery platforms
- Kindeva’s breadth of expertise and legacy of innovation
- Options for MAP customization
- Our extensive capacity across clinical and commercial production
Related resources
Explore our other resources to discover valuable insights on the latest trends in drug delivery.
Microneedle array patch characterization recording
Microneedle array patches (MAPs) have the potential to transform delivery of medications and vaccines. While this innovative drug delivery format could result in improved efficiency across a wide range of therapeutics, it also brings critical challenges. To successfully move from concept to commercialization, MAP manufacturers must consider scalability, regulatory compliance, and other complexities. In this […]
Learn More
Microneedle array patch characterization presentation
Microneedle array patches (MAPs) are a transformative innovation in drug delivery, with the potential to redefine how medications and vaccines reach patients. MAPs promise a simpler, more effective way to deliver a wide range of therapeutics, but their journey from concept to commercialization is filled with critical challenges. From scaling manufacturing to ensuring regulatory compliance, […]
Learn MoreLet’s transform tomorrow together
Every patient deserves a brighter tomorrow. As your strategic partner, we are dedicated to building your lasting legacy and helping you fast-track healthier tomorrows. You dream it, we deliver it.